diagnostic-accuracy
(2)
URO-1, Inc.
URO-1, Inc. is a Greensboro, North Carolina medical device company modernizing the prostate biopsy, a procedure its founder describes as largely unchanged in decades. Founded in 2017 by prostate cancer survivor and serial MedTech entrepreneur Ted Belleza, URO-1 makes the FDA-cleared SUREcore biopsy needle and coreCARE tissue transfer system, a paired platform built to collect larger, more intact tissue cores and preserve their integrity on the way to pathology. The company reports its needle hit 92% targeting accuracy in MRI-ultrasound fusion biopsies versus 36% for conventional needles, and began commercial launch in January 2025 following an $8 million Series A.
DeepLook Medical
DeepLook Medical is a Scottsdale, Arizona medical imaging company whose FDA-cleared software, DL Precise, helps radiologists see and measure suspicious lesions that hide inside dense breast tissue. Using proprietary shape-recognition algorithms that overlay directly on existing imaging systems, the tool delivers single-click segmentation across mammography, ultrasound, CT and MRI. Led by CEO Marissa Fayer, the company is in commercial use at major U.S. health systems and closed a Series A led by Xcellerant Ventures in 2024.